Dermatology Doctors in Bluffton, SC Accepting Medicare

7 Dermatology doctors found. Showing 1 - 7

Frank Zurfley Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7 Arley Way Ste 101, Bluffton, SC 29910 Phone: 843-837-4400    Fax: 438-837-4440

Dr. Michael Dale Sarradet, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7 Arley Way Ste 101, Bluffton, SC 29910 Phone: 843-837-4400    Fax: 843-837-4440

Audrey Klenke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7 Mallett Way, Bluffton, SC 29910 Phone: 843-815-6699    Fax: 843-815-6695

Ms. Heather Kerle Casalicchio, PA Dermatology Medicare: Accepting Medicare Assignments Practice Location: 350 Fording Island Rd Ste 100, Bluffton, SC 29910 Phone: 843-837-4400    Fax: 843-837-4440

Dr. Joseph Wilson Mcgowan Iv, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7 Arley Way Ste 101, Bluffton, SC 29910 Phone: 843-837-4400

Carmen Anderson Traywick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 350 Fording Island Road, Suite 100, Bluffton, SC 29910 Phone: 843-837-4400

Rosanne M Paul, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 350 Fording Island Rd Ste 100, Bluffton, SC 29910 Phone: 843-837-4400    Fax: 843-837-4440

News Archive

Study looks at sleep deprived nurses and driving

Hospital staff nurses who work extended hours, work at night, struggle to remain awake at work, or obtain less sleep are more likely to experience a drowsy driving episode, according to a study published in the December 1 issue of the journal SLEEP.

Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.

Study assesses possible links between pain medications and recurrent breast cancer risk

Women who receive one common pain drug during mastectomy are less likely to develop recurrent breast cancer in the years following surgery, suggests a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients

A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Read more Medical News

› Verified 8 days ago